المؤلفون: Park, John, Rugo, HS, Jo, A, Franco, SX, Stopeck, AT, Glencer, A, Lahiri, S, Arbushites, MC, Scott, J, Park, JW, Hudis, C

URL الوصول: https://escholarship.org/uc/item/2z30g6mg

المؤلفون: Schwarzberg LS, Franco SX, Florance A, O'Rourke L, Maltzman J, Johnston S

المصدر: Oncologist; Feb2010, Vol. 15 Issue 2, p122-129, 8p

المؤلفون: Gomez HL, Doval DC, Chavez MA, Ang PC, Aziz Z, Nag S, Ng C, Franco SX, Chow LW, Arbushites MC, Casey MA, Berger MS, Stein SH, Sledge GW

المصدر: Journal of Clinical Oncology; 6/20/2008, Vol. 26 Issue 18, p2999-3005, 7p

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Dawood S; Department of Medical Oncology, Mediclinic City Hospital - North Wing, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai Health Care City, Dubai, United Arab Emirates. shaheenah@post.harvard.edu., Konstantinova M; Department of Antitumor Drug Therapy, F. VladimirskIy Moscow Regional Research Clinical Institute (MONIKI), Moscow, Russia., Perazzo F; Department of Oncology, Centro de Educación Médicae Investigaciones Clínicas (CEMIC), Ciudad De Buenos Aires, Argentina., Kim SB; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Songpa-gu, Seoul, Korea., Villarreal-Garza C; Centro de Cancer de Mama, Hospital Zambrano Hellion, Tecnologico de Monterrey, Mexico; Depto. de Investigacion, Instituto Nacional de Cancerologia, Tlalpan, Ciudad de México., Franco SX; Department of Oncology, Clínica del Country, Bogotá, Colombia, Colombia., Simon SD; Centro Paulista de Oncologia (CPO), Faria Lima, 4300 - Vila Olímpia, São Paulo, Brazil., El-Nahas T; Kasr Al Ainy Hospital, Cairo university, Giza, Egypt.

المصدر: Chinese clinical oncology [Chin Clin Oncol] 2020 Oct; Vol. 9 (5), pp. 61. Date of Electronic Publication: 2020 Aug 17.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: AME Publishing Company Country of Publication: China NLM ID: 101608375 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2304-3873 (Electronic) Linking ISSN: 23043865 NLM ISO Abbreviation: Chin Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Immunotherapy/*methods , Poly(ADP-ribose) Polymerase Inhibitors/*therapeutic use , Triple Negative Breast Neoplasms/*drug therapy, Adult ; Female ; Group Processes ; Humans ; Neoplasm Metastasis ; Poly(ADP-ribose) Polymerase Inhibitors/pharmacology

المؤلفون: Esteva FJ; Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. fjesteva@mdanderson.org, Franco SX, Hagan MK, Brewster AM, Somer RA, Williams W, Florance AM, Turner S, Stein S, Perez A

المصدر: The oncologist [Oncologist] 2013 Jun; Vol. 18 (6), pp. 661-6. Date of Electronic Publication: 2013 May 22.

نوع المنشور: Clinical Trial; Journal Article

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Monoclonal, Humanized/*administration & dosage , Breast Neoplasms/*drug therapy , Neoplasm Metastasis/*drug therapy , Paclitaxel/*administration & dosage , Quinazolines/*administration & dosage, Adult ; Antineoplastic Combined Chemotherapy Protocols ; Breast Neoplasms/genetics ; Breast Neoplasms/pathology ; Drug Administration Schedule ; Drug-Related Side Effects and Adverse Reactions/pathology ; Female ; Humans ; Lapatinib ; Middle Aged ; Neoplasm Metastasis/pathology ; Receptor, ErbB-2/genetics ; Trastuzumab

المؤلفون: Rugo HS; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, 1600 Divisadero St., 2nd Floor, Box 1710, B-608, San Francisco, CA 94143, USA. hrugo@medicine.ucsf.edu, Chien AJ, Franco SX, Stopeck AT, Glencer A, Lahiri S, Arbushites MC, Scott J, Park JW, Hudis C, Nulsen B, Dickler MN

المصدر: Breast cancer research and treatment [Breast Cancer Res Treat] 2012 Jul; Vol. 134 (1), pp. 13-20. Date of Electronic Publication: 2011 Dec 24.

نوع المنشور: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE

مواضيع طبية MeSH: Gene Expression*, Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Breast Neoplasms/*drug therapy , Receptor, ErbB-2/*metabolism, Antibodies, Monoclonal, Humanized/administration & dosage ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Bevacizumab ; Breast Neoplasms/metabolism ; Breast Neoplasms/pathology ; Disease-Free Survival ; Female ; Humans ; Lapatinib ; Middle Aged ; Neoplasm Metastasis ; Proportional Hazards Models ; Quinazolines/administration & dosage ; Receptor, ErbB-2/genetics ; Treatment Outcome

المؤلفون: Schwartzberg LS; The West Clinic, Memphis, Tennessee, USA., Franco SX, Florance A, O'Rourke L, Maltzman J, Johnston S

المصدر: The oncologist [Oncologist] 2010; Vol. 15 (2), pp. 122-9. Date of Electronic Publication: 2010 Feb 15.

نوع المنشور: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*administration & dosage , Breast Neoplasms/*drug therapy , Nitriles/*therapeutic use , Receptor, ErbB-2/*biosynthesis , Triazoles/*therapeutic use, Aged ; Aged, 80 and over ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Breast Neoplasms/enzymology ; Breast Neoplasms/metabolism ; Disease-Free Survival ; Double-Blind Method ; Drug Synergism ; Female ; Humans ; Lapatinib ; Letrozole ; Middle Aged ; Nitriles/administration & dosage ; Nitriles/adverse effects ; Placebos ; Postmenopause ; Quinazolines/administration & dosage ; Quinazolines/adverse effects ; Receptor, ErbB-2/antagonists & inhibitors ; Receptors, Estrogen/biosynthesis ; Receptors, Progesterone/biosynthesis ; Treatment Outcome ; Triazoles/administration & dosage ; Triazoles/adverse effects